摘要:
The present invention concerns compounds for use as a medicine having the formula the N-oxide forms, the salts, the quaternary amines and stereochemically isomeric forms thereof, wherein R1 represents hydrogen, C1-6alkyl, C1-4alkylthio, C1-4alkyloxy, or halo; R2 represents hydrogen or C1-6alkyl; R3 represents phenyl substituted with halo, cyano, C1-4alkyloxy, C1-4alkylthio, C1-6alkyl, haloC1-6alkyl; 2-thienyl; or 3-thienyl, R4 represents hydrogen; or R2 and R4 form an extra bond, which are active against dermatophytes, and their preparation; it further relates to compositions comprising them, as well as their use as a medicine.
摘要翻译:本发明涉及用作具有N-氧化物形式的药物的化合物,其盐,季胺和立体化学异构形式,其中R 1表示氢,C 1-6烷基,C 1-4烷硫基,C 1-4烷氧基或卤素 ; R 2表示氢或C 1-6烷基; R 3表示被卤素,氰基,C 1-4烷氧基,C 1-4烷硫基,C 1-6烷基,卤代C 1-6烷基取代的苯基; 2-噻吩基; 或3-噻吩基,R 4表示氢; 或R2和R4形成额外的键,其对皮肤癣菌有活性,并且它们的制备; 它还涉及包含它们的组合物以及它们作为药物的用途。
摘要:
The present invention concerns compounds for use as a medicine having the formula (I), the N-oxide forms, the salts, the quaternary amines and stereochemically isomeric forms thereof, wherein R1 represents hydrogen, C1-6 alkyl, C1-4alkylthio, C1-4alkyloxy, or halo; R2 represents hydrogen or C1-6alkyl; R3 represents phenyl substituted with halo, cyano, C1-4alkyloxy, C1-4alkylthio, C1-6alkyl, haloC1-6alkyl; 2-thienyl; or 3-thienyl, R4 represents hydrogen; or R2 and R4 form an extra bond, which are active against dermatophytes, and their preparation; it further relates to compositions comprising them, as well as their use as a medicine.
摘要翻译:本发明涉及用作具有式(I)的药物,N-氧化物形式,其盐,季胺及其立体化学异构形式的化合物,其中R 1表示氢, C 1-4烷基,C 1-4烷基硫基,C 1-4烷基氧基或卤素; R 2表示氢或C 1-6烷基; R 3表示被卤素,氰基,C 1-4烷氧基,C 1-4烷基硫基,C 1-6烷基取代的苯基 烷基,卤代C 1-6烷基; 2-噻吩基; 或3-噻吩基,R 4表示氢; 或R 2和R 4形成对皮肤癣菌有活性的额外的结合,及其制备; 它还涉及包含它们的组合物以及它们作为药物的用途。
摘要:
The present invention concerns compounds for use as a medicine having the formula the N-oxide forms, the salts, the quaternary amines and stereochemically isomeric forms thereof, wherein R1 represents hydrogen, C1-6alkyl, C1-4alkylthio, C1-4alkyloxy, or halo; R2 represents hydrogen or C1-6alkyl; R3 represents phenyl substituted with halo, cyano, C1-4alkyloxy, C1-4alkylthio, C1-6alkyl, haloC1-6alkyl; 2-thienyl; or 3-thienyl, R4 represents hydrogen; or R2 and R4 form an extra bond, which are active against dermatophytes, and their preparation; it further relates to compositions comprising them, as well as their use as a medicine.
摘要翻译:本发明涉及用作具有N-氧化物形式的药物的化合物,其盐,季胺和立体化学异构形式,其中R 1表示氢,C 1〜 C 1 -C 6烷基,C 1-4烷基硫基,C 1-4烷基氧基或卤素; R 2表示氢或C 1-6烷基; R 3表示被卤素,氰基,C 1-4烷氧基,C 1-4烷基硫基,C 1-6烷基取代的苯基 烷基,卤代C 1-6烷基; 2-噻吩基; 或3-噻吩基,R 4表示氢; 或R 2和R 4形成对皮肤癣菌有活性的额外的结合,及其制备; 它还涉及包含它们的组合物以及它们作为药物的用途。
摘要:
This invention comprises the novel compounds of formula (I) wherein n, m, t, R1, R2, R3, R4, L, Q, X, Y, Z and have defined meanings, having histone deacetylase inhibiting enzymatic activity; their preparation, compositions containing them and their use as a medicine.
摘要:
This invention comprises the novel compounds of formula (I) wherein n, t, R1, R2, R3, R4, L, Q, X, Y, Z and have defined meanings, having histone deacetylase inhibiting enzymatic activity; their preparation, compositions containing them and their use as a medicine.
摘要:
N-aryl piperidine substituted biphenylcarboxamides compounds of formula (I) methods for preparing such compounds, pharmaceutical compositions comprising said compounds as well as the use of said compounds as a medicine for the treatment of hyperlipidemia, obesity and type II diabetes.
摘要:
This invention comprises the novel compounds of formula (I) wherein n, R1, R2, R3, R4, L, Q, X, Y, Z and have defined meanings, having histone deacetylase inhibiting enzymatic activity; their preparation, compositions containing them and their use as a medicine.
摘要:
The invention further relates to a DGAT inhibitor of formula (I), including any stereochemically isomeric form thereof, wherein A represents CH or N; the dotted line represents an optional bond in case A represents a carbon atom; X represents —NRx—C(═O)—; —Z—C(═O)—; —Z—NRx—C(═O)—; —S(═O)p-; C(═S)—; —NRx—C(═S)—; —Z—C(═S)—; —Z—NRx—C(═S)—; —O—C(═O)—; —C(═O)—C(═O)—; R1 represents a 5-membered monocyclic heterocycle containing at least 2 heteroatoms; a 6-membered aromatic monocyclic heterocycle; or a 5-membered heterocycle containing at least 2 heteroatoms fused with phenyl, cyclohexyl or a 5-or 6-membered heterocycle; wherein each of said heterocycles may optionally be substituted; R2 represents R3; R3 represents C3-6cycloalkyl, phenyl, naphtalenyl, 2,3-dihydro-1,4-benzodioxinyl, 1,3-benzodioxlyl, 2,3-dihydrobenzofuranyl or a 6-membered aromatic heterocycle containing 1 or 2 N atoms, wherein said C3-6cycloalkyl, phenyl, naphtalenyl, 2,3-dihydro-1,4-benzo-dioxinyl, 1,3-benzodioxolyl, 2,3-dihydrobenzofuranyl or 6-membered aromatic heterocycle may optionally be substituted; a N-oxide thereof, a pharmaceutically acceptable salt thereof or a solvate thereof. The invention further relates to methods for preparing such compounds, pharmaceutical compositions comprising said compounds as well as the use as a medicine of said compounds.
摘要:
This invention comprises the novel compounds of formula (I) wherein n, R1, R2, R3, R4, L, Q, X, Y, Z and have defined meanings, having histone deacetylase inhibiting enzymatic activity; their preparation, compositions containing them and their use as a medicine.
摘要:
Biphenylcarboxamide compounds of formula (I) methods for preparing compounds of formula (I), pharmaceutical compositions comprising compounds of formula (I) as well as the use of compounds of formula (I) as a medicine for the treatment of hyperlipidemia, obesity and type II diabetes.